Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,278 | 87 | 90.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $247.00 | 1 | 9.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $540.13 | 18 | $0 (2019) |
| Allergan, Inc. | $341.61 | 8 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $294.61 | 13 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $255.44 | 8 | $0 (2022) |
| Notal Vision, Inc. | $247.00 | 1 | $0 (2021) |
| Aerie Pharmaceuticals, Inc. | $241.40 | 7 | $0 (2021) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $132.48 | 7 | $0 (2021) |
| Oyster Point Pharma, Inc. | $67.99 | 3 | $0 (2022) |
| Dompe US, Inc. | $52.09 | 3 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $49.85 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.54 | 1 | Amgen Inc. ($26.54) |
| 2022 | $181.24 | 9 | Oyster Point Pharma, Inc. ($67.99) |
| 2021 | $469.54 | 11 | Notal Vision, Inc. ($247.00) |
| 2020 | $73.68 | 4 | Sun Pharmaceutical Industries Inc. ($23.15) |
| 2019 | $569.08 | 23 | Allergan Inc. ($144.58) |
| 2018 | $582.90 | 21 | Shire North American Group Inc ($141.68) |
| 2017 | $622.34 | 19 | Shire North American Group Inc ($353.11) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/08/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/17/2022 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: GLAUCOMA | ||||||
| 08/26/2022 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), PROLENSA, LOTEMAX SM | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Ophthalmology | ||||||
| 08/03/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/26/2022 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), PROLENSA, LOTEMAX SM | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Ophthalmology | ||||||
| 06/22/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: DRY EYE | ||||||
| 05/11/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: DRY EYE | ||||||
| 04/13/2022 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Ophthalmology | ||||||
| 02/16/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/19/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: DRY EYE | ||||||
| 12/15/2021 | Notal Vision, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $247.00 | General |
| 12/15/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Ophthalmology | ||||||
| 09/08/2021 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/17/2021 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: SOLUTION/ DROPS | ||||||
| 07/28/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), BromSite, Xelpros | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Ophthalmology | ||||||
| 07/07/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Ophthalmology | ||||||
| 06/30/2021 | Aerie Pharmaceuticals, Inc. | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Glaucoma | ||||||
| 06/21/2021 | Aerie Pharmaceuticals, Inc. | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $66.22 | General |
| Category: Glaucoma | ||||||
| 06/15/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/11/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), BromSite, Xelpros | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Ophthalmology | ||||||
| 04/13/2021 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Glaucoma | ||||||
| 03/25/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/04/2020 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug), BROMSITE | Food and Beverage | Cash or cash equivalent | $23.15 | General |
| Category: Ophthalmology | ||||||
| 01/22/2020 | Allergan, Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: DRY EYE | ||||||
| 01/07/2020 | Johnson & Johnson Vision Care, Inc. | Acuvue (Device) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Soft Contact Lenses | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 385 | 430 | $59,654 | $35,171 |
| 2022 | 8 | 1,123 | 1,293 | $210,990 | $92,135 |
| 2021 | 9 | 1,295 | 1,474 | $228,400 | $118,084 |
| 2020 | 6 | 649 | 747 | $111,590 | $56,605 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 118 | $15,340 | $9,495 | 61.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 75 | 97 | $12,610 | $7,853 | 62.3% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 48 | 48 | $8,880 | $5,274 | 59.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $6,328 | $4,044 | 63.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 33 | $6,105 | $3,581 | 58.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 17 | 17 | $3,842 | $2,199 | 57.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 37 | 38 | $3,306 | $1,130 | 34.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 16 | $1,248 | $820.32 | 65.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 34 | 35 | $1,995 | $774.17 | 38.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 512 | 523 | $104,405 | $46,773 | 44.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 246 | 396 | $58,880 | $28,285 | 48.0% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 84 | 90 | $9,808 | $4,748 | 48.4% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 40 | 40 | $8,824 | $4,165 | 47.2% |
| 92133 | Imaging of optic nerve | Office | 2022 | 143 | 145 | $14,371 | $3,864 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 46 | $10,120 | $3,199 | 31.6% |
| 92134 | Imaging of retina | Office | 2022 | 36 | 37 | $3,657 | $938.57 | 25.7% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 16 | 16 | $925.00 | $162.52 | 17.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 670 | 707 | $138,100 | $69,867 | 50.6% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 245 | 380 | $42,100 | $27,523 | 65.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 67 | 67 | $10,380 | $5,074 | 48.9% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 75 | 80 | $8,800 | $4,505 | 51.2% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 36 | 36 | $6,940 | $3,770 | 54.3% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 123 | 124 | $12,400 | $3,639 | 29.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 36 | $6,160 | $2,765 | 44.9% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 22 | 22 | $2,200 | $755.21 | 34.3% |
About Dr. Michael Baum, MD
Dr. Michael Baum, MD is a Ophthalmology healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689662140.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Baum, MD has received a total of $2,525 in payments from pharmaceutical and medical device companies, with $26.54 received in 2024. These payments were reported across 88 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,278).
As a Medicare-enrolled provider, Baum has provided services to 3,452 Medicare beneficiaries, totaling 3,944 services with total Medicare billing of $301,996. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Silver Spring, MD
- Active Since 10/10/2005
- Last Updated 02/22/2010
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689662140
Products in Payments
- XIIDRA (Drug) $593.25
- LUMIGAN (Drug) $300.37
- VYZULTA (Drug) $156.58
- Rhopressa (Drug) $146.94
- SIMBRINZA (Biological) $136.38
- rhopressa (Drug) $81.29
- TYRVAYA (Drug) $67.99
- BESIVANCE (Drug) $67.81
- PROLENSA (Drug) $64.06
- Omidria (Drug) $48.76
- RESTASIS (Drug) $41.24
- LOTEMAX SM (Drug) $38.95
- ACTHAR (Biological) $37.94
- DUREZOL (Drug) $37.07
- Oxervate (Drug) $37.00
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $36.97
- BROMSITE (Drug) $36.34
- Cequa (Drug) $36.02
- TRAVATAN Z (Drug) $28.87
- TEPEZZA (Biological) $26.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Silver Spring
Aziz Khanifar, Md, MD
Ophthalmology — Payments: $75,587
Dr. Aisha Macedo, M.d, M.D
Ophthalmology — Payments: $7,885
Dr. Saman Ghahremani, M.d, M.D
Ophthalmology — Payments: $4,494
Arusha Gupta, M.d, M.D
Ophthalmology — Payments: $4,299
Dr. Thomas Yau, Md, MD
Ophthalmology — Payments: $3,934
Dr. Beth Schwartz, M.d, M.D
Ophthalmology — Payments: $2,730